🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
the study intends to observe the outcome of interventions (concentrated gro...
Status
Unknown
Location
Dow University of health sciences
Start Date
2020-12-17
Trial ID
NCT05480631
This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Status
Terminated
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00400764
Treatments Being Tested
This study will assess the efficacy and safety of mosunetuzumab in combinat...
Status
Active Not Recruiting
Location
City of Hope Cancer Center
Start Date
2022-04-25
Trial ID
NCT05171647
Treatments Being Tested
Everolimus is an oral mTOR inhibitor with demonstrated preliminary efficacy...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2009-05
Trial ID
NCT00869999
Treatments Being Tested
Multicenter, double-blind, randomized, placebo-controlled phase I/II study ...
Status
Recruiting
Location
Clinica Universidad de Navarra
Start Date
2020-03-11
Trial ID
NCT04163562
The main purpose of this study is to explore the sequential therapeutic eff...
Status
Unknown
Location
Southwest Hospital of Third Millitary Medical University
Start Date
2016-03
Trial ID
NCT02737085
Treatments Being Tested
This study is to investigate the clinical efficacy and safety of RL-1 Novel...
Status
Unknown
Location
Third Affiliated Hospital of Sun Yat-sen University
Start Date
2019-12
Trial ID
NCT04195282
Treatments Being Tested
Toxicities related to pediatric cancer treatment can lead to significant il...
Status
Terminated
Location
University of Virginia
Start Date
2016-08
Trial ID
NCT02624388
This is a Phase 1 study evaluating the safety of ABT-263 administered in co...
Status
Completed
Location
Site Reference ID/Investigator# 17841
Start Date
2009-11
Trial ID
NCT00868413
This is a prospective, single center, randomized, double-blinded, placebo-c...
Status
Completed
Location
Medical University of Vienna, Department of Clinical Pharmacology
Start Date
2014-10
Trial ID
NCT02284360
Treatments Being Tested